Rescue of cGMP Kinase I Knockout Mice by Smooth Muscle–Specific Expression of Either Isozyme
暂无分享,去创建一个
F. Hofmann | R. Feil | J. Schlossmann | S. Feil | J. Wegener | R. Lukowski | Dominik Bernhard | N. Valtcheva | P. Weinmeister | Silke Weber | René Wörner
[1] M. Wilm,et al. IRAG mediates NO/cGMP-dependent inhibition of platelet aggregation and thrombus formation. , 2007, Blood.
[2] U. Förstermann,et al. Endothelial Nitric Oxide Synthase in Vascular Disease: From Marvel to Menace , 2006, Circulation.
[3] A. Diedrich,et al. NO-dependent blood pressure regulation in RGS2-deficient mice. , 2006, American journal of physiology. Regulatory, integrative and comparative physiology.
[4] M. Mendelsohn,et al. Cyclic GMP-dependent Protein Kinase Iα Inhibits Thrombin Receptor-mediated Calcium Mobilization in Vascular Smooth Muscle Cells* , 2006, Journal of Biological Chemistry.
[5] F. Hofmann,et al. Distribution of cGMP-dependent protein kinase type I and its isoforms in the mouse brain and retina , 2005, Neuroscience.
[6] Xiaoguang Sun,et al. RGS2 Is a Mediator of Nitric Oxide Action on Blood Pressure and Vasoconstrictor Signaling , 2005, Molecular Pharmacology.
[7] F. Hofmann,et al. cGMP-Dependent Protein Kinase Mediates NO- but not Acetylcholine-Induced Dilations in Resistance Vessels In Vivo , 2004, Hypertension.
[8] F. Hofmann,et al. IRAG is essential for relaxation of receptor‐triggered smooth muscle contraction by cGMP kinase , 2004, The EMBO journal.
[9] F. Hofmann,et al. Distribution of IRAG and cGKI‐isoforms in murine tissues , 2004, FEBS letters.
[10] T. Haystead,et al. Smooth Muscle Phosphatase Is Regulated in Vivo by Exclusion of Phosphorylation of Threonine 696 of MYPT1 by Phosphorylation of Serine 695 in Response to Cyclic Nucleotides* , 2004, Journal of Biological Chemistry.
[11] R. Fässler,et al. Modulation of Ca2+ Sensitivity by Cyclic Nucleotides in Smooth Muscle from Protein Kinase G-deficient Mice* , 2004, Journal of Biological Chemistry.
[12] F. Brozovich,et al. Unzipping the Role of Myosin Light Chain Phosphatase in Smooth Muscle Cell Relaxation* , 2004, Journal of Biological Chemistry.
[13] R. Karas,et al. Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure , 2003, Nature Medicine.
[14] Céline Marionneau,et al. RhoA Expression Is Controlled by Nitric Oxide through cGMP-dependent Protein Kinase Activation* , 2003, The Journal of Biological Chemistry.
[15] F. Hofmann,et al. cGMP-Dependent Protein Kinase I Mediates the Negative Inotropic Effect of cGMP in the Murine Myocardium , 2002, Circulation research.
[16] F. Hofmann,et al. Molecular Determinants of the Interaction between the Inositol 1,4,5-Trisphosphate Receptor-associated cGMP Kinase Substrate (IRAG) and cGMP Kinase Iβ* 210 , 2001, The Journal of Biological Chemistry.
[17] D. Metzger,et al. Temporally controlled somatic mutagenesis in smooth muscle , 2000, Genesis.
[18] S. Lohmann,et al. Cyclic GMP-dependent Protein Kinase Signaling Pathway Inhibits RhoA-induced Ca2+ Sensitization of Contraction in Vascular Smooth Muscle* , 2000, The Journal of Biological Chemistry.
[19] G. Neubauer,et al. Regulation of intracellular calcium by a signalling complex of IRAG, IP3 receptor and cGMP kinase Iβ , 2000, Nature.
[20] T. Lincoln,et al. Regulation of myosin phosphatase by a specific interaction with cGMP- dependent protein kinase Ialpha. , 1999, Science.
[21] P. Klatt,et al. Defective smooth muscle regulation in cGMP kinase I‐deficient mice , 1998, The EMBO journal.
[22] E. Olson,et al. SM22 alpha, a marker of adult smooth muscle, is expressed in multiple myogenic lineages during embryogenesis. , 1996, Circulation research.
[23] E. Morrisey,et al. Structure and Expression of a Smooth Muscle Cell-specific Gene, SM22α (*) , 1995, The Journal of Biological Chemistry.
[24] F. Hofmann,et al. Detection of cGMP dependent protein kinase isozymes by specific antibodies. , 1992, European journal of biochemistry.
[25] J. Corbin,et al. Relaxation of pig coronary arteries by new and potent cGMP analogs that selectively activate type I alpha, compared with type I beta, cGMP-dependent protein kinase. , 1992, Molecular pharmacology.
[26] F. Hofmann,et al. The activation of expressed cGMP‐dependent protein kinase isozymes Iα and Iβ is determined by the different amino‐termini , 1991 .
[27] U. Walter,et al. Stoichiometric and reversible phosphorylation of a 46-kDa protein in human platelets in response to cGMP- and cAMP-elevating vasodilators. , 1990, The Journal of biological chemistry.
[28] F. Hofmann,et al. The cDNA of the two isoforms of bovine cGMP‐dependent protein kinase , 1989, FEBS letters.
[29] J. Corbin,et al. Characterization of a novel isozyme of cGMP-dependent protein kinase from bovine aorta. , 1989, The Journal of biological chemistry.
[30] F. Hofmann,et al. Function of cGMP-dependent protein kinases as revealed by gene deletion. , 2006, Physiological reviews.
[31] T. Lincoln,et al. Regulation of vascular smooth muscle cell phenotype by cyclic GMP and cyclic GMP-dependent protein kinase. , 2006, Frontiers in bioscience : a journal and virtual library.
[32] M. Biel,et al. Mouse Models of NO/Natriuretic Peptide/cGMP Kinase Signaling , 2004 .
[33] A. Konnerth,et al. Downloaded from http://circres.ahajournals.org / by guest on February 21, 2013Functional Reconstitution of Vascular Smooth Muscle Cells With cGMP-Dependent Protein Kinase I Isoforms , 2002 .
[34] E. Morrisey,et al. Structure and expression of a smooth muscle cell-specific gene, SM22 alpha. , 1995, The Journal of biological chemistry.
[35] F. Hofmann,et al. The activation of expressed cGMP-dependent protein kinase isozymes I alpha and I beta is determined by the different amino-termini. , 1991, European journal of biochemistry.